Official publication of Rawalpindi Medical University
Nitrofurantoin and Fosfomycin, effective oral empirical treatment options against multidrug resistant Escherichia coli
PDF

How to Cite

1.
Saima Naseem, Ambreen Fatima, Sahar Iqbal, Fatima Fasih, Syed Talha Naeem, Uzma Bukhari. Nitrofurantoin and Fosfomycin, effective oral empirical treatment options against multidrug resistant Escherichia coli. JRMC [Internet]. 2021 Dec. 31 [cited 2024 May 26];25(4). Available from: https://www.journalrmc.com/index.php/JRMC/article/view/1734

Abstract

Objective
The present study is designed to monitor antibiotic susceptibility pattern of Escherichia coli to assist in forecasting empirical therapy of urinary tract infection.
Methodology
It is a retrospective cross sectional study. It was carried out at Dow Diagnostic Research and Reference Laboratory for a period of 3 months from February 2017 to April 2017. A data of total 5000 urine culture and sensitivity test reports was taken from the medical record. The data was analyzed by SPSS version 16.
Results
Out of 5000 urine samples processed, 1565 showed significant bacterial growth. Escherichia coli was the most common pathogen isolated. Meropenem, Amikacin, Fosfomycin and Nitrofurantoin respectively were found to be the most sensitive antibiotics against Escherichia coli.
Conclusion
Fosfomycin and Nitrofurantoin are effective oral antibiotics against Escherichia coli causing urinary tract infection. The present study may help clinicians in making rational choice of empirical treatment of the patients.

https://doi.org/10.37939/jrmc.v25i4.1734
PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2021 Saima Naseem, Ambreen Fatima, Sahar Iqbal, Fatima Fasih, Syed Talha Naeem, Uzma Bukhari